The purpose of this investigation is to examine the mechanisms mediating vascular dysfunction in women who have had gestational diabetes and how metformin may be a valuable treatment tool to improve microvascular function in these women before the onset of disease.
Gestational Diabetes
The purpose of this investigation is to examine the mechanisms mediating vascular dysfunction in women who have had gestational diabetes and how metformin may be a valuable treatment tool to improve microvascular function in these women before the onset of disease.
Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
-
University of Iowa, Iowa City, Iowa, United States, 52242
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 45 Years
FEMALE
Yes
Anna Stanhewicz, PhD,
Anna Stanhewicz, PhD, PRINCIPAL_INVESTIGATOR, University of Iowa
2029-07